Circulating and Disseminated Tumor Cells in the Clinical Management of Breast Cancer Patients: Unanswered Questions

Publisher： Karger

E-ISSN： 1423-0232|76|6|375-386

ISSN： 0030-2414

Source： Oncology, Vol.76, Iss.6, 2009-04, pp. : 375-386

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparison of HER2 Expression in Primary Tumor and Disseminated Tumor Cells in the Bone Marrow of Breast Cancer Patients

By  

Oncology, Vol. 90, Iss. 4, 2016-03 ,pp. : 232-238

Karger

Access to resources Recommend Favorite

Relationship between Circulating Tumor Cells, Blood Coagulation, and Urokinase‐Plasminogen‐Activator System in Early Breast Cancer Patients

By  

THE BREAST JOURNAL, Vol. 21, Iss. 2, 2015-03 ,pp. : 155-160

John Wiley & Sons Inc

Access to resources Recommend Favorite

Expression of insulin‐like growth factor‐1 receptor in circulating tumor cells of patients with breast cancer is associated with patient outcomes

By  

Molecular Oncology, Vol. 12, Iss. 1, 2018-01 ,pp. : 21-32

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical significance of circulating tumor cells in peripheral blood from patients with gastric cancer

By  

CANCER, Vol. 119, Iss. 22, 2013-11 ,pp. : 3984-3991

John Wiley & Sons Inc

Access to resources Recommend Favorite

Identification of genomic signatures in circulating tumor cells from breast cancer

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 137, Iss. 2, 2015-07 ,pp. : 332-344

John Wiley & Sons Inc

Access to resources Recommend Favorite